早期脏缩减轻心脏功能障碍心力衰竭与保存的喷射分数的心脏功能障碍
Jake E Doiron1, Zhen Li2, Xiaoman Yu2
1Department of Pharmacology and Experimental Therapeutics Louisiana State University Health Sciences Center New Orleans LA USA.
Journal of the American Heart Association
|February 14, 2024
概括
早期的射频同情性缩 (RF-RDN) 通过减少纤维化和炎症,在老鼠中改善了心力衰竭与保存的喷射分数 (HFpEF). 晚期RF-RDN没有显示任何益处,这表明时间对于这种潜在的HFpEF处理至关重要.
科学领域:
- 心血管研究研究心血管研究
- 脏生理学 脏生理学
- 医疗干预 医疗干预
背景情况:
- 交感神经系统在调节血压和心脏功能方面发挥着关键作用.
- 过度活跃的交感神经活动与心力衰竭的发展有关,心力衰竭具有保存的喷射分数 (HFpEF).
- 在HFpEF中研究交感性缩 (RDN) 的治疗窗口至关重要.
研究的目的:
- 评估HFpEF进展的不同阶段射频损伤 (RF-RDN) 的疗效.
- 确定早期与晚期RF-RDN对心血管功能,运动能力和心脏病理学的影响.
主要方法:
- 雄性ZSF1肥胖大鼠,HFpEF的一个模型,在8周或20周时接受了RF-RDN或假手术.
- 评估了心血管功能,运动耐受性和心纤维化.
- 通过测量上腺素和氨酸氧化酶水平,确认了损伤;损伤,炎症和纤维化标志物也被分析.
主要成果:
- 在早期和晚期治疗组中,RF-RDN显著降低了脏的诺亚上腺素和氨酸氧酶.
- 早期的RF-RDN (8周) 减轻了心脏功能障碍,减少了心纤维化,改善了血管反应能力.
- 这些好处与降低损伤,炎症 (NLRP3 / IL-1β) 和益纤维素介质有关.
- 晚期RF-RDN (20周) 对心血管参数没有显著的有益影响.
结论:
- 早期的RF-RDN通过减轻纤维化和炎症,显示出对HFpEF进展的保护作用.
- 射频-RDN的治疗益处,包括脏保护和改善左心室功能,当在疾病的晚期给予时就会丧失.
- RDN可能代表HFpEF的一种可行的治疗策略,特别是当在这种全身炎症状况的早期阶段实施时.
更多相关视频
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.5K
07:49Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
1.4K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
431
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431
01:22Heart Failure Drugs: Diuretics
381
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
381
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:22Heart Failure Drugs: β-Blockers
340
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
340
01:27Dialysis
310
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
310